General Information of the Compound
| Compound ID |
CP0066173
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-hydroxy-2,2-diphenylacetamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
4099-51-8
A-phenyl-
AC1L6390
AC1Q5QC3
AKOS022308585
BDBM50207561
BENZENEACETAMIDE,N-HYDROXY-A-PHENYL-
CHEMBL396097
CTK8I6435
DTXSID10286297
Diphenylacetohydroxamic acid
Diphenylacetohydroxamic acid, >
MFCD16314231
N-Hydroxy diphenylacetamide
N-Hydroxydiphenylacetamide
N-hydroxy-2,2-diphenylacetamide
NSC-44620
NSC44620
SCHEMBL2839032
ZINC4522248
benzeneacetamide, n-hydroxy-
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C14H13NO2
|
||||||||||||||||||
| Molecular Weight |
227.263
|
||||||||||||||||||
| Canonical SMILES |
ONC(=O)C(c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C14H13NO2/c16-14(15-17)13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10,13,17H,(H,15,16)
Show/Hide
|
||||||||||||||||||
| InChIKey |
OFSBBVCLWMCGNY-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
4099-51-8
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound